OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging Biomarkers for Immunotherapy in Glioblastoma
Nadia Mensali, Else Marit Inderberg
Cancers (2022) Vol. 14, Iss. 8, pp. 1940-1940
Open Access | Times Cited: 9
Nadia Mensali, Else Marit Inderberg
Cancers (2022) Vol. 14, Iss. 8, pp. 1940-1940
Open Access | Times Cited: 9
Showing 9 citing articles:
Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
Qi Wan, Clifford Lindsay, Chenxi Zhang, et al.
Cancer Imaging (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Qi Wan, Clifford Lindsay, Chenxi Zhang, et al.
Cancer Imaging (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Tumor Microenvironment and Microvascular Density in Human Glioblastoma
Roberto Tamma, Giuseppe Ingravallo, Tiziana Annese, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 11-11
Open Access | Times Cited: 24
Roberto Tamma, Giuseppe Ingravallo, Tiziana Annese, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 11-11
Open Access | Times Cited: 24
Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 21
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 21
Exosomal circ_0001583 Drives Glioblastoma Cell Advancement Through the miR-647/CKAP2L Pathway
Yuhao Zhang, Shiming Liu, Cheng Wu, et al.
Molecular Neurobiology (2025)
Open Access
Yuhao Zhang, Shiming Liu, Cheng Wu, et al.
Molecular Neurobiology (2025)
Open Access
Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma
Yuekun Wang, Shenglan Li, Yichen Peng, et al.
Cancer Innovation (2023) Vol. 2, Iss. 2, pp. 114-130
Open Access | Times Cited: 5
Yuekun Wang, Shenglan Li, Yichen Peng, et al.
Cancer Innovation (2023) Vol. 2, Iss. 2, pp. 114-130
Open Access | Times Cited: 5
The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside
Ying Qi, Xiaoming Huang, Chunxia Ji, et al.
Translational Oncology (2023) Vol. 39, pp. 101793-101793
Open Access | Times Cited: 3
Ying Qi, Xiaoming Huang, Chunxia Ji, et al.
Translational Oncology (2023) Vol. 39, pp. 101793-101793
Open Access | Times Cited: 3
Biomarkers in the Era of Precision Oncology
Constantin N. Baxevanis
Cancers (2023) Vol. 15, Iss. 6, pp. 1782-1782
Open Access | Times Cited: 2
Constantin N. Baxevanis
Cancers (2023) Vol. 15, Iss. 6, pp. 1782-1782
Open Access | Times Cited: 2
Dynamics of tumor in situ fluid circulating tumor DNA in recurrent glioblastomas forecasts treatment efficacy of immune checkpoint blockade coupled with low-dose bevacizumab
Dayang Wang, Jiubing Zhang, Chaojie Bu, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access
Dayang Wang, Jiubing Zhang, Chaojie Bu, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access
Constructing a signature based on the SIRT family to help the prognosis and treatment sensitivity in glioma patients
Feiyue Xuan, Zhiwei Zhang, Kuili Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 2
Feiyue Xuan, Zhiwei Zhang, Kuili Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 2
